Add Yahoo as a preferred source to see more of our stories on Google. Here’s why your immortality serum isn’t hitting CVS anytime soon: cellular reprogramming carries serious cancer risk. The same ...

A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug, which the company claims has restored vision in monkeys, for ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

June 2 (Reuters) - The U.S. Food and Drug Administration on Tuesday proposed allowing makers of cell and gene therapies targeting rare and life-threatening diseases to ‌use existing scientific ...

Add Yahoo as a preferred source to see more of our stories on Google. Staff walk among the buildings at the the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, ...